Literature DB >> 19351886

Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis.

Haiming Dai1, X Wei Meng, Sun-Hee Lee, Paula A Schneider, Scott H Kaufmann.   

Abstract

The release of cytochrome c from mitochondria, which leads to activation of the intrinsic apoptotic pathway, is regulated by interactions of Bax and Bak with antiapoptotic Bcl-2 family members. The factors that regulate these interactions are, at the present time, incompletely understood. Recent studies showing preferences in binding between synthetic Bcl-2 homology domain 3 and antiapoptotic Bcl-2 family members in vitro have suggested that the antiapoptotic proteins Mcl-1 and Bcl-x(L), but not Bcl-2, restrain proapoptotic Bak from inducing mitochondrial membrane permeabilization and apoptosis. Here we show that Bak protein has a much higher affinity than the 26-amino acid Bak Bcl-2 homology domain 3 for Bcl-2, that some naturally occurring Bcl-2 allelic variants have an affinity for full-length Bak that is only 3-fold lower than that of Mcl-1, and that endogenous levels of these Bcl-2 variants (which are as much as 40-fold more abundant than Mcl-1) restrain part of the Bak in intact lymphoid cells. In addition, we demonstrate that Bcl-2 variants can, depending on their affinity for Bak, substitute for Mcl-1 in protecting cells. Thus, the ability of Bcl-2 to protect cells from activated Bak depends on two important contextual variables, the identity of the Bcl-2 present and the amount expressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351886      PMCID: PMC2709361          DOI: 10.1074/jbc.M109.004770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function.

Authors:  William A Cliby; Kriste A Lewis; Kia K Lilly; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

2.  Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak.

Authors:  G J Griffiths; B M Corfe; P Savory; S Leech; M D Esposti; J A Hickman; C Dive
Journal:  Oncogene       Date:  2001-11-15       Impact factor: 9.867

3.  Solution structure of the antiapoptotic protein bcl-2.

Authors:  A M Petros; A Medek; D G Nettesheim; D H Kim; H S Yoon; K Swift; E D Matayoshi; T Oltersdorf; S W Fesik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

Authors:  M L Cleary; S D Smith; J Sklar
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

5.  Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain.

Authors:  Xue Wei Meng; Michael P Heldebrant; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

6.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

Authors:  A Strasser; A W Harris; M L Bath; S Cory
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

7.  Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells.

Authors:  D A Moulding; R V Giles; D G Spiller; M R White; D M Tidd; S W Edwards
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

8.  Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix.

Authors:  Loren D Walensky; Andrew L Kung; Iris Escher; Thomas J Malia; Scott Barbuto; Renee D Wright; Gerhard Wagner; Gregory L Verdine; Stanley J Korsmeyer
Journal:  Science       Date:  2004-09-03       Impact factor: 47.728

9.  Involvement of the bcl-2 gene in human follicular lymphoma.

Authors:  Y Tsujimoto; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

Review 10.  Cytochrome C-mediated apoptosis.

Authors:  Xuejun Jiang; Xiaodong Wang
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

View more
  31 in total

1.  Bax dimerizes via a symmetric BH3:groove interface during apoptosis.

Authors:  G Dewson; S Ma; P Frederick; C Hockings; I Tan; T Kratina; R M Kluck
Journal:  Cell Death Differ       Date:  2011-10-21       Impact factor: 15.828

2.  Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

Authors:  Susan L Slager; Christine F Skibola; Maria Chiara Di Bernardo; Lucia Conde; Peter Broderick; Shannon K McDonnell; Lynn R Goldin; Naomi Croft; Amy Holroyd; Shelley Harris; Jacques Riby; Daniel J Serie; Neil E Kay; Timothy G Call; Paige M Bracci; Eran Halperin; Mark C Lanasa; Julie M Cunningham; Jose F Leis; Vicki A Morrison; Logan G Spector; Celine M Vachon; Tait D Shanafelt; Sara S Strom; Nicola J Camp; J Brice Weinberg; Estella Matutes; Neil E Caporaso; Rachel Wade; Martin J S Dyer; Claire Dearden; James R Cerhan; Daniel Catovsky; Richard S Houlston
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

3.  Heterodimerization of BAK and MCL-1 activated by detergent micelles.

Authors:  Qian Liu; Kalle Gehring
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

Review 4.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

Review 5.  Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment.

Authors:  Cristina Correia; Sun-Hee Lee; X Wei Meng; Nicole D Vincelette; Katherine L B Knorr; Husheng Ding; Grzegorz S Nowakowski; Haiming Dai; Scott H Kaufmann
Journal:  Biochim Biophys Acta       Date:  2015-03-27

6.  Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.

Authors:  Xue Wei Meng; Michael P Heldebrant; Karen S Flatten; David A Loegering; Haiming Dai; Paula A Schneider; Timothy S Gomez; Kevin L Peterson; Sergey A Trushin; Allan D Hess; B Douglas Smith; Judith E Karp; Daniel D Billadeau; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

7.  Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation.

Authors:  Husheng Ding; Jennifer Hackbarth; Paula A Schneider; Kevin L Peterson; X Wei Meng; Haiming Dai; Thomas E Witzig; Scott H Kaufmann
Journal:  Blood       Date:  2011-06-14       Impact factor: 22.113

8.  Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.

Authors:  Haiming Dai; Husheng Ding; X Wei Meng; Sun-Hee Lee; Paula A Schneider; Scott H Kaufmann
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

9.  Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.

Authors:  Joachim C Mertens; Christian D Fingas; John D Christensen; Rory L Smoot; Steven F Bronk; Nathan W Werneburg; Michael P Gustafson; Allan B Dietz; Lewis R Roberts; Alphonse E Sirica; Gregory J Gores
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

10.  Mcl-1 promotes survival of thymocytes by inhibition of Bak in a pathway separate from Bcl-2.

Authors:  A Dunkle; I Dzhagalov; Y-W He
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.